SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 4/19/2018 5:45:45 AM - Followers: 1387 - Board type: Free - Posts Today: 2

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

SureTrader
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#218583  Sticky Note MOR sells 9.55M ADSs@$25.04 in Nasdaq IPO: DewDiligence 04/18/18 06:51:32 PM
#218574  Sticky Note GNCA highlights neoadjuvant-selection process: DewDiligence 04/18/18 04:29:56 PM
#218567  Sticky Note ARNA- Good interview by Amit Munshi on Mufaso 04/18/18 10:24:51 AM
#218561  Sticky Note BMY: I think the logic behind that tweet JohnWayne 04/17/18 10:15:06 PM
#218539  Sticky Note ASMB - 4/12/18 CC notes mcbio 04/16/18 09:20:48 PM
#218435  Sticky Note RVNC does have the Botox cell line, as DewDiligence 04/11/18 05:26:29 PM
#218594   NBRV Sheff made some bullish comments on the bUrRpPPP! 04/19/18 05:45:45 AM
#218593   CCP just shut down an Android app downloaded NY1972 04/19/18 12:06:11 AM
#218592   CLSD - it appears, if I am reading Bickema 04/18/18 11:18:45 PM
#218591   Ok, I see you were talking about OS jq1234 04/18/18 10:58:53 PM
#218590   BMY: “One minor correction to your post, OS secondary JohnWayne 04/18/18 10:35:24 PM
#218589   ASMB - What is the real reason for mcbio 04/18/18 10:33:37 PM
#218588   Re: Aprea/(KDEV.ST) - Looks to me like it's mcbio 04/18/18 09:22:54 PM
#218587   CLSD - Anyone looked into or have an Bickema 04/18/18 09:12:45 PM
#218586   FDA approves AZN’s Tagrisso for first-line metastatic or DewDiligence 04/18/18 07:57:29 PM
#218585   ASMB—The phase-2a trial design is ok, but I DewDiligence 04/18/18 07:21:22 PM
#218584   Re: ASMB mcbio 04/18/18 07:07:10 PM
#218583   MOR sells 9.55M ADSs@$25.04 in Nasdaq IPO: DewDiligence 04/18/18 06:51:32 PM
#218582   Re: BMY I-O counterpoint DewDiligence 04/18/18 05:18:51 PM
#218581   Other 1st line ph3 trials mainly from melanoma jq1234 04/18/18 05:13:46 PM
#218580   I don’t think the market is pricing nivolumab DewDiligence 04/18/18 05:09:04 PM
#218579   CheckMate-227: Agreed completely. If much higher percentage of randomized jq1234 04/18/18 05:00:33 PM
#218577   VTVT—>4-bagger off last week’s low, but still -33% DewDiligence 04/18/18 04:49:25 PM
#218576   Opdivo BLA for monotherapy in third-line SCLC has DewDiligence 04/18/18 04:42:18 PM
#218575   Re: ASMB CC First P2a study designed DewDiligence 04/18/18 04:36:11 PM
#218574   GNCA highlights neoadjuvant-selection process: DewDiligence 04/18/18 04:29:56 PM
#218573   I’ve seen similar hedged language by other companies, DewDiligence 04/18/18 04:25:27 PM
#218572   CATB closes +13% from yesterday’s AH low upon Titan V 04/18/18 04:18:16 PM
#218571   Looks to me like it's likely real. But biomaven0 04/18/18 03:07:16 PM
#218570   Do you attribute the increased efficacy, OS, of north40000 04/18/18 01:47:37 PM
#218569   QBL News; MMJ Solution on addiction!!Up 19% weekly. Alexulf 04/18/18 11:59:48 AM
#218568   Agree. I listened to the interview as well. kris_kade 04/18/18 11:12:22 AM
#218567   ARNA- Good interview by Amit Munshi on Mufaso 04/18/18 10:24:51 AM
#218566   BLCM sells 9.20M* shares @$7.50—a 16% discount to DewDiligence 04/18/18 10:21:16 AM
#218565   “Those are the verbatim phrases used by AGN's biotech_researcher 04/18/18 09:33:32 AM
#218564   Barclays analyst Douglas Tsao says that while he'd DewDiligence 04/18/18 09:21:05 AM
#218563   BMY dough (@tgtxdough) 4/18/18, 7:42 AM BMO $BMY key growth driver biotech_researcher 04/18/18 08:21:05 AM
#218562   Barclays sees 'significant challenges' for Botox biosimilar jbog 04/18/18 07:30:33 AM
#218561   BMY: I think the logic behind that tweet JohnWayne 04/17/18 10:15:06 PM
#218560   4,000,000 Reasons to Back China Biotech jbog 04/17/18 07:46:40 PM
#218559   FDA approves RARE’s Crysveta for X–linked hypophosphatemia: DewDiligence 04/17/18 06:16:19 PM
#218558   I don't follow CATB closely enough to address DewDiligence 04/17/18 04:56:04 PM
#218557   Any thoughts on CATB in general Dew? They Titan V 04/17/18 04:49:22 PM
#218556   CATB—(-6%/AH)—lays off 42% of workforce: DewDiligence 04/17/18 04:36:52 PM
#218555   Dumbing down in NYT article on statins: DewDiligence 04/17/18 02:32:53 PM
#218554   Vaccibody—>a neoantigen-vaccine company I hadn’t heard of: DewDiligence 04/17/18 02:29:08 PM
#218553   Re: BMY's prospects in first-line NSCLC DewDiligence 04/17/18 02:18:58 PM
#218552   FDA approves RIGL’s Tavalisse (fostamatinib) for second-line ITP; DewDiligence 04/17/18 02:09:42 PM
#218551   Anti-PD-1 response restored after introduction of diverse microbiome biocqr 04/17/18 12:36:47 PM
#218550   Findings showed that the KEYTRUDA-pemetrexed-platinum chemotherapy combin vinmantoo 04/17/18 12:30:28 PM
#218548   CLVS raises $460M* in common stock and convertible debt: DewDiligence 04/17/18 11:27:27 AM
#218547   RVNC—I expect an update at the Investor Day DewDiligence 04/17/18 11:14:29 AM
#218546   Revance -- Plantar Fasciitis mouton29 04/17/18 10:49:38 AM
#218545   Re: GWPH haysaw 04/17/18 09:48:13 AM
#218544   This is an odd partnership insofar as BMY biopharm 04/17/18 09:23:33 AM
#218543   ARQL licenses Derazantinib to Basilea, a Swiss company bladerunner1717 04/17/18 09:19:33 AM
PostSubject